메뉴 건너뛰기




Volumn 63, Issue 4, 2015, Pages 1040-1041

PIVKA-II is an independent prognostic factor for overall survival of HCC patients and maybe associated with epithelial-mesenchymal transition

Author keywords

[No Author keywords available]

Indexed keywords

DECARBOXYPROTHROMBIN; GELATINASE B; TUMOR MARKER; UVOMORULIN; VIMENTIN; ALPHA FETOPROTEIN; BIOLOGICAL MARKER; PROTEIN PRECURSOR; PROTHROMBIN;

EID: 84941933928     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.04.031     Document Type: Letter
Times cited : (18)

References (7)
  • 1
    • 84926415936 scopus 로고    scopus 로고
    • Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion
    • N. Poté, F. Cauchy, M. Albuquerque, H. Voitot, J. Belghiti, L. Castera, and et al. Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion J Hepatol 62 2015 848 854
    • (2015) J Hepatol , vol.62 , pp. 848-854
    • Poté, N.1    Cauchy, F.2    Albuquerque, M.3    Voitot, H.4    Belghiti, J.5    Castera, L.6
  • 2
    • 84908426283 scopus 로고    scopus 로고
    • Evaluation of serum PIVKA-II and MIF as diagnostic markers for HCV/HBV induced hepatocellular carcinoma
    • M.M. Kamel, M.F. Saad, A.A. Mahmoud, A.A. Edries, and A.S. Abdel-Moneim Evaluation of serum PIVKA-II and MIF as diagnostic markers for HCV/HBV induced hepatocellular carcinoma Microb Pathog 77 2014 31 35
    • (2014) Microb Pathog , vol.77 , pp. 31-35
    • Kamel, M.M.1    Saad, M.F.2    Mahmoud, A.A.3    Edries, A.A.4    Abdel-Moneim, A.S.5
  • 4
    • 84885725653 scopus 로고    scopus 로고
    • PIVKA-II is a useful marker in patients with modified UICC T3 stage hepatocellular carcinoma
    • J.M. Kim, C.H. Kwon, J.W. Joh, J.B. Park, J.H. Lee, S.J. Kim, and et al. PIVKA-II is a useful marker in patients with modified UICC T3 stage hepatocellular carcinoma Hepatogastroenterology 60 2013 1456 1462
    • (2013) Hepatogastroenterology , vol.60 , pp. 1456-1462
    • Kim, J.M.1    Kwon, C.H.2    Joh, J.W.3    Park, J.B.4    Lee, J.H.5    Kim, S.J.6
  • 5
    • 84873716720 scopus 로고    scopus 로고
    • Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP
    • J.Y. Choi, S.W. Jung, H.Y. Kim, M. Kim, Y. Kim, D.G. Kim, and et al. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP World J Gastroenterol 19 2013 339 346
    • (2013) World J Gastroenterol , vol.19 , pp. 339-346
    • Choi, J.Y.1    Jung, S.W.2    Kim, H.Y.3    Kim, M.4    Kim, Y.5    Kim, D.G.6
  • 6
    • 84877746461 scopus 로고    scopus 로고
    • Protein induced by Vitamin K antagonist-II (PIVKA-II) is a reliable prognostic factor in small hepatocellular carcinoma
    • J.M. Kim, C. Hyuck, D. Kwon, J.W. Joh, J.H. Lee, S.W. Paik, and et al. Protein induced by vitamin K antagonist-II (PIVKA-II) is a reliable prognostic factor in small hepatocellular carcinoma World J Surg 37 2013 1371 1378
    • (2013) World J Surg , vol.37 , pp. 1371-1378
    • Kim, J.M.1    Hyuck, C.2    Kwon, D.3    Joh, J.W.4    Lee, J.H.5    Paik, S.W.6
  • 7
    • 84906837694 scopus 로고    scopus 로고
    • Elevated PIVKA-II is associated with early recurrence and poor prognosis in BCLC 0-A hepatocellular carcinomas
    • B.L. Wang, Q.W. Tan, X.H. Gao, J. Wu, and W. Guo Elevated PIVKA-II is associated with early recurrence and poor prognosis in BCLC 0-A hepatocellular carcinomas Asian Pac J Cancer Prev 15 2014 6673 6678
    • (2014) Asian Pac J Cancer Prev , vol.15 , pp. 6673-6678
    • Wang, B.L.1    Tan, Q.W.2    Gao, X.H.3    Wu, J.4    Guo, W.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.